% Expired Patents = 85.7

EPO Patents = 2

Forward Citations = 6

Loading Chart...

6 inventors (with patents filed for the assignee):

Robin Mark Bannister (6 out of 80 patents)

John Brew (5 out of 65 patents)

Andrew Douglas Baxter (2 out of 44 patents)

4. Gregory Alan Stoloff (1 out of 43 patents)

5. Wilson Romero Caparros-Wanderley (1 out of 28 patents)

6. Michael Harvey Lyne (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 9849110 - Intermittent fibrate administration method (2017-12-26),

2. 9539240 - Drug combinations and methods for reducing or maintaining cholesterol or HDL/LDL levels (2017-01-10),

3. 9056140 - Pharmaceutical compound (2015-06-16),

4. 8703158 - Theobromine for the treatment of cough (2014-04-22),

5. 8188152 - 2-aminoalcohols for the treatment of neurodegenerative diseases (2012-05-29),

6. 8188150 - Use of beta-aminoalcohols in the treatment of inflammatory disorders and pain (2012-05-29),

7. 8030357 - Use of bupropion metabolites for the treatment of inflammatory disorders (2011-10-04),

Biocopea Limited is a leading provider of innovative and sustainable solutions for the pharmaceutical and biotechnology industries. With a focus on research and development, Biocopea specializes in creating cutting-edge products and technologies that help improve patient outcomes and drive the industry forward. Their team of experts is dedicated to delivering high-quality solutions that meet the unique needs of each client and contribute to a healthier world.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

7 Patents

#433 in London

#2,339 in United Kingdom

London, United Kingdom

Biocopea Limited